1169095

AX Pharmaceutical Corporation — FEI 3010738198

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 6, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Concord (Canada)